仙乐健康(300791) - 2022 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2022 was ¥421,248,609.14, representing a decrease of 17.01% compared to ¥507,560,431.75 in the same period last year[3] - Net profit attributable to shareholders was ¥14,638,612.62, down 74.48% from ¥57,360,400.88 year-on-year[3] - The net profit after deducting non-recurring gains and losses was ¥4,309,880.47, a decline of 91.80% compared to ¥52,543,436.24 in the previous year[3] - Basic earnings per share were ¥0.32, reflecting a decrease of 75.00% from the previous year[4] - Total operating revenue for the current period is ¥421,248,609.14, a decrease of 17.0% from ¥507,560,431.75 in the previous period[20] - Net profit for the current period is ¥14,638,612.62, a decline of 74.5% compared to ¥57,360,400.88 in the previous period[22] - Operating profit decreased significantly to ¥17,746,209.01, down 75.2% from ¥71,514,280.72 in the previous period[22] - Total comprehensive income for the current period is ¥14,138,814.21, down 73.6% from ¥53,416,011.26 in the previous period[24] - Basic earnings per share decreased to ¥0.08 from ¥0.32 in the previous period, reflecting a 75.0% decline[24] Cash Flow - The net cash flow from operating activities increased significantly to ¥19,502,319.27, marking a 613.94% increase[4] - Cash flow from operating activities generated ¥139,235,270.31, a substantial increase from ¥19,502,319.27 in the previous period[27] - Net cash flow from financing activities was -1,426,287.02, compared to -188,744.43 in the previous period[28] - Cash and cash equivalents at the end of the period totaled 654,971,448.23, down from 708,732,992.29 at the beginning of the period[28] - The net increase in cash and cash equivalents was -53,761,544.06, compared to -29,760,225.19 in the previous period[28] - Cash inflow from financing activities amounted to 1,747.50[28] - Cash outflow for dividend distribution, profit, or interest payments was 142,541.93[28] - The impact of exchange rate changes on cash and cash equivalents was -544,121.66[28] - The company reported a cash flow from financing activities net amount of -1,426,287.02[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,820,110,170.19, showing a slight increase of 0.80%[4] - The total assets of the company increased to RMB 3,850,720,519.92 from RMB 3,820,110,170.19, reflecting a growth of approximately 0.8%[19] - Current assets decreased to RMB 1,860,827,021.99 from RMB 1,914,522,146.55, a decline of about 2.8%[15] - Cash and cash equivalents at the end of the period were RMB 660,301,918.94, down from RMB 715,544,087.29, representing a decrease of approximately 7.7%[13] - Accounts receivable decreased significantly to RMB 228,352,215.15 from RMB 341,758,634.13, a reduction of about 33.3%[13] - Inventory increased to RMB 299,895,377.28 from RMB 239,613,375.43, marking an increase of approximately 25.2%[13] - Total liabilities rose to RMB 1,287,387,493.27 from RMB 1,275,330,463.97, an increase of about 0.9%[17] - The company's equity attributable to shareholders increased to RMB 2,563,333,026.65 from RMB 2,544,779,706.22, reflecting a growth of approximately 0.7%[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,857[8] - The largest shareholder, Guangdong Guanghui Investment Co., Ltd., held 43.16% of the shares, totaling 77,760,000 shares[8] Expenses - Total operating costs decreased to ¥418,839,974.40, down 5.7% from ¥444,345,727.83 in the previous period[20] - Research and development expenses increased to ¥18,723,894.19, up 6.7% from ¥17,541,154.80 in the previous period[20] - Financial expenses rose to ¥10,524,804.69, an increase of 72.5% from ¥6,116,844.80 in the previous period[22] - Other income increased to ¥7,208,240.83, up 72.5% from ¥4,175,224.20 in the previous period[22] Other Information - The company reported a significant increase in prepaid expenses, which rose by 255.02% to ¥43,915,383.92[7] - The company reported a decrease in employee compensation payable from RMB 37,802,330.45 to RMB 17,368,648.10, a decline of about 54.0%[16] - The company’s long-term investments increased to RMB 390,567,465.84 from RMB 337,791,232.93, an increase of approximately 15.6%[15] - The company’s total non-current assets rose to RMB 1,989,893,497.93 from RMB 1,905,588,023.64, an increase of about 4.4%[15] - The first quarter report was not audited[29]